FDA accepts Fluzone intradermal sBLA

FDA accepted for review an sBLA from sanofi-aventis Group (Euronext:SAN; NYSE:SNY) for Fluzone intradermal influenza virus vaccine to prevent seasonal influenza in patients 18-64 years of age. The com...